Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Thoracic 1Lymphoid 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 3863Motor Activity 228Neoplasms 201Prostatic Neoplasms 167Colorectal Neoplasms 146Lung Neoplasms 139Lymphedema 125Fatigue 104Ovarian Neoplasms 98Carcinoma, Intraductal, Noninfiltrating 94Colonic Neoplasms 86Breast Cancer Lymphedema 86Pain 81Breast Cancer Female 76Anxiety Disorders 76Uterine Cervical Neoplasms 73Depression 70Triple Negative Breast Neoplasms 66Breast Carcinoma In Situ 66Head and Neck Neoplasms 55Pain, Postoperative 54Obesity 54Neoplasm Metastasis 48Melanoma 42Endometrial Neoplasms 39Pancreatic Neoplasms 38Lymphoma 38Carcinoma, Non-Small-Cell Lung 34Sleep Initiation and Maintenance Disorders 33Sarcoma 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Atrial Fibrillation × Breast × Clear all
NCT04331535 2022-10-03

GenoVA

Boston VA Research Institute, Inc.

Phase NA Unknown
1,076 enrolled
BreastGastrointestinalGenitourinary

Genetic Risk Score, Atrial Fibrillation, Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Type 2, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡